Go to deals
Consumer & Retail | Healthcare

Apostrophe has been acquired by Hims & Hers Health, Inc.

The private shareholders of Apostrophe have sold the company to Hims & Hers Health, Inc.

Founded in 2012 and based in Oakland, California, Apostrophe is a direct-to-patient teledermatology platform that provides individuals with access to tailored, clinical-quality treatment plans that are prescribed by board-certified dermatologists. Through its vertically integrated in-house pharmacy, the company creates premium Apostrophe-branded products that use bespoke combinations of topical formulas and oral medications to meet the unique needs of patients. Driven by its innovative telehealth model, well-recognized skincare brand and visionary leadership team, the company has experienced rapid growth over the past several years.

Based in San Francisco, California, Hims & Hers is a leading multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers.

Oaklins’ team in Los Angeles acted as advisor to the private shareholders of Apostrophe in this transaction.

Parties

Talk to the deal team

Adam Abramowitz

Managing Director
Los Angeles, United States
Oaklins Intrepid

Michael Garcia

Managing Director
Los Angeles, United States
Oaklins Intrepid

Hayden Rosenthal

Associate Director
Los Angeles, United States
Oaklins Intrepid

Related deals

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Healthcare

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth, as well as investing in service quality, innovation and efficiency.

Learn more
HD Clinical Ltd. has been acquired by NEXUS AG
Healthcare | TMT

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

Learn more
Peter Möhrle has sold GROFA Group to DARFON Electronics Corp.
Private Equity | Consumer & Retail

Peter Möhrle has sold GROFA Group to DARFON Electronics Corp.

Peter Möhrle Holding GmbH & Co. KG has successfully completed the sale of GROFA Group to DARFON Electronics Corp.

Learn more